The sub-acute toxicity of kavalactone in rats: a study of the effect of oral doses and the mechanism of toxicity in combination with ethanol

References

• Allen, J., and Bradley, R.D., 2011. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. Journal of Alternative and Complementary Medicine (New York, N.Y.), 17 (9), 827–833.
   PubMed Web of Science ®Google Scholar
• Amacher, D.E., Schomaker, S.J., and Burkhardt, J.E., 1998. The relationship among microsomal enzyme induction, liver weight and histological change in rat toxicology studies. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 36 (9-10), 831–839.
   PubMedGoogle Scholar
• Amorim  , Maria, F.D., et al., 2007. The controvertible role of kava (Piper methysticum G. Foster) an anxiolytic herb, on toxic hepatitis. Revista Brasileira de Farmacognosia, 17 (3), 448–454.
   Google Scholar
• Anke, J., and Ramzan, I., 2004. Kava hepatotoxicity: are we any closer to the truth? Planta Medica, 70 (03), 193–196.
   PubMedGoogle Scholar
• Aporosa, S., 2020. De-mythologizing and re-branding the traditional drink kava. Drug Science, Policy and Law, 5, 1–13.
   Google Scholar
• Becker, M.W., et al., 2019. Liver transplantation and the use of KAVA: case report. Phytomedicine : international Journal of Phytotherapy and Phytopharmacology, 56, 21–26.
   PubMed Web of Science ®Google Scholar
• Behl, M., et al., 2011. Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 49 (11), 2820–2829.
   PubMed Web of Science ®Google Scholar
• Bilia, A.R., et al., 2004. Analysis of kavalactones from Piper methysticum (kava-kava). Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 812 (1-2), 203–214.
   PubMed Web of Science ®Google Scholar
• Cairney, S., et al., 2003. Saccade and cognitive function in chronic kava users. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 28 (2), 389–396.
   PubMed Web of Science ®Google Scholar
• Clayton, N.P., et al., 2007. Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft Fur Toxikologische Pathologie, 58 (4), 223–236.
   PubMedGoogle Scholar
• Clough, A.R. 2003. Health effects of heavy kava use on indigenous Australians. PhD Thesis. Northern Territory University.
   Google Scholar
• Clough, A.R., Bailie, R.S., and Currie, B., 2003. Liver function test abnormalities in users of aqueous kava extracts. Journal of Toxicology: Clinical Toxicology, 41 (6), 821–829.
   PubMed Web of Science ®Google Scholar
• da Silva, S., et al., 2021. Piper methysticum G. Forst (Piperaceae) in the central nervous system: phytochemistry, pharmacology and mechanism of action. Research, Society and Development, 10 (12), e216101220479–e216101220479.
   Google Scholar
• Dennehy, C.E., Tsourounis, C., and Miller, A.E., 2005. Evaluation of herbal dietary supplements marketed on the internet for recreational use. The Annals of Pharmacotherapy, 39 (10), 1634–1639.
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova, A.T., et al., 2001. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proceedings of the National Academy of Sciences of the United States of America, 98 (6), 3404–3409.
   PubMed Web of Science ®Google Scholar
• Ebadi, M., 2006. Pharmacodynamic basis of herbal medicine. London: CRC Press.
   Google Scholar
• El-Kholy, S.M.S., and El-Salam, S.A., 2011. Kava extract drug: what is the actual risk of hepatotoxicity in adult male albino rats? The Egyptian Journal of Histology, 34 (4), 697–704.
   Google Scholar
• Fu, P.P., et al., 2008. Toxicity of kava kava. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews, 26 (1), 89–112.
   PubMed Web of Science ®Google Scholar
• Guo, L., et al., 2009. Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 47 (2), 433–442.
   PubMedGoogle Scholar
• Gyengesi, E., Paxinos, G., and Andrews, Z.B., 2012. Oxidative stress in the hypothalamus: the importance of calcium signaling and mitochondrial ROS in body weight regulation. Current Neuropharmacology, 10 (4), 344–353.
   PubMedGoogle Scholar
• Jamieson, D.D., and Duffield, P.H., 1990. The antinociceptive actions of kava components in mice. Clinical and Experimental Pharmacology & Physiology, 17 (7), 495–507.
   PubMed Web of Science ®Google Scholar
• Jussofie, A., Schmiz, A., and Hiemke, C., 1994. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology, 116 (4), 469–474.
   PubMed Web of Science ®Google Scholar
• Li, X.Z., and Ramzan, I., 2010. Role of ethanol in kava hepatotoxicity. Phytotherapy Research: PTR, 24 (4), 475–480.
   PubMedGoogle Scholar
• Limdi, J.K., and Hyde, G.M., 2003. Evaluation of abnormal liver function tests. Postgraduate Medical Journal, 79 (932), 307–312.
   PubMedGoogle Scholar
• Liu, L‐l., et al., 2005. Altered expression of cytochrome P450 and possible correlation with preneoplastic changes in early stage of rat hepatocarcinogenesis. Acta Pharmacologica Sinica, 26 (6), 737–744.
   PubMedGoogle Scholar
• Mathews, J.D., et al., 1988. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community. The Medical Journal of Australia, 148 (11), 548–555.
   PubMed Web of Science ®Google Scholar
• Moulds, R.F., and Malani, J., 2003. Kava: herbal panacea or liver poison? The Medical Journal of Australia, 178 (9), 451–453.
   PubMedGoogle Scholar
• Narayanapillai, S.C., et al., 2014. Flavokawains a and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL/6 mice. Chemical Research in Toxicology, 27 (10), 1871–1876.
   PubMed Web of Science ®Google Scholar
• Rowe, A., Zhang, L.Y., and Ramzan, I., 2011. Toxicokinetics of kava. Advances in Pharmacological Sciences, 2011, 326724.
   PubMedGoogle Scholar
• Salehi, B., et al., 2019. Piper species: a comprehensive review on their phytochemistry, biological activities and applications. Molecules, 24 (7), 1364.
   PubMed Web of Science ®Google Scholar
• Showman, A.F., et al., 2015. Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology. Fitoterapia, 100, 56–67.
   PubMed Web of Science ®Google Scholar
• Singh, R., et al., 2009. Autophagy regulates lipid metabolism. Nature, 458 (7242), 1131–1135.
   PubMed Web of Science ®Google Scholar
• Sorrentino, L., Capasso, A., and Schmidt, M., 2006. Safety of ethanolic kava extract: results of a study of chronic toxicity in rats. Phytomedicine : international Journal of Phytotherapy and Phytopharmacology, 13 (8), 542–549.
   PubMed Web of Science ®Google Scholar
• Sun, L., et al., 2020. Serum exosomal miR-122 as a potential diagnostic and prognostic biomarker of colorectal cancer with liver metastasis. Journal of Cancer, 11 (3), 630–637.
   PubMedGoogle Scholar
• Tauchen, J., 2020. Natural products and their (semi-)synthetic forms in the treatment of migraine: history and current status. Current Medicinal Chemistry, 27 (23), 3784–3808.
   PubMedGoogle Scholar
• Teschke, R., 2010. Kava hepatotoxicity. A clinical review. Annals of Hepatology, 9 (3), 251–265.
   PubMed Web of Science ®Google Scholar
• Thomsen, M., and Schmidt, M., 2021. Health policy versus kava (Piper methysticum): anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop. Journal of Ethnopharmacology, 268, 113582.
   PubMedGoogle Scholar
• Tugcu, G., Kırmızıbekmez, H., and Aydın, A., 2020. The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 145, 111663.
   PubMedGoogle Scholar
• Ullah, H., et al., 2020. Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice. BMC Complementary Medicine and Therapies, 20 (1), 1–14.
   PubMedGoogle Scholar
• Van Der Watt, G., Laugharne, J., and Janca, A., 2008. Complementary and alternative medicine in the treatment of anxiety and depression. Current Opinion in Psychiatry, 21 (1), 37–42.
   PubMed Web of Science ®Google Scholar
• White, C.M., 2018. The pharmacology, pharmacokinetics, efficacy, and adverse events associated with kava. The. Journal of Clinical Pharmacology, 58 (11), 1396–1405.
   PubMedGoogle Scholar
• Whitton, P.A., et al., 2003. Kava lactones and the kava-kava controversy. Phytochemistry, 64 (3), 673–679.
   PubMedGoogle Scholar